China Medical & HealthCare Group Limited provided group earnings guidance for the year ended 31 December 2022. For the year, the group is expected to record the Net Loss which represents (a) an approximately 5% to 35% decrease when compared with the Net Loss for the year ended 31 December 2021; but (b) an approximately 65% to 95% increase when compared with the Net Loss for the year ended 31 December 2021 excluding the one-off non-recurring item of impairment loss under expected credit loss model recognized on loan receivable. This was mainly due to the adverse factors set out in the Profit Warning Announcement and further to (i) the loss on fair value changes on investment properties compared with a gain recorded for the year ended 31 December 2021; (ii) the provision for properties under development for sale and properties held for sale; and (iii) the written-off of property plant and equipment.